Drug intelligence / Profile preview

Eroxon Intense

Development stage
Preclinical
Lead developer
Futura Medical
Modality
Small Molecules
Administration
Topical
01

Overview

Eroxon Intense is a topical gel developed by Futura Medical for the treatment of erectile dysfunction (ED) in men. As a stronger formulation of the original Eroxon (MED3000), it is designed to provide a more intense sensory experience to facilitate the achievement of an erection. The gel operates via a unique evaporative mode of action: upon application to the glans penis, volatile components evaporate rapidly, creating a sequence of cooling and recovery warming. This rapid temperature shift stimulates thermoreceptors (nerve sensors) in the glans, which in turn triggers the local release of nitric oxide. The resulting vasodilation and smooth muscle relaxation in the penis lead to increased blood flow and an erection, typically within ten minutes. Classified as a medical device, Eroxon Intense is intended for over-the-counter use and has shown high efficacy and satisfaction rates in clinical trials.

Brand names
Eroxon Intense
02

Targets

NO2- (Nitrite)

Beyond the preview

Go deeper on Eroxon Intense.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eroxon Intense.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call